Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $94.9 Million. The most recent transaction as insider was on Aug 09, 2022, when has been sold 522 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M

0.97% 3M change

8.33% 12M change

Total Value Held $94.9 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 09 2022	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,624,753 Common Stock
Jul 25 2022	SELL Open market or private sale	$1,627,500 $162.75 p/Share	10,000 Reduced 0.61%	1,624,231 Common Stock
Jul 25 2022	BUY Exercise of conversion of derivative security	$109,000 $10.9 p/Share	10,000 Added 0.61%	1,634,231 Common Stock
Jul 13 2022	SELL Open market or private sale	$844,400 $168.88 p/Share	5,000 Reduced 0.31%	1,624,231 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,629,231 Common Stock
Jul 12 2022	SELL Open market or private sale	$873,650 $174.73 p/Share	5,000 Reduced 0.31%	1,624,231 Common Stock
Jul 12 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,629,231 Common Stock
Jun 24 2022	SELL Open market or private sale	$719,900 $143.98 p/Share	5,000 Reduced 0.31%	1,624,231 Common Stock
Jun 24 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,629,231 Common Stock
Jun 23 2022	SELL Open market or private sale	$679,800 $135.96 p/Share	5,000 Reduced 0.31%	1,624,231 Common Stock
Jun 23 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,629,231 Common Stock
Jun 13 2022	SELL Open market or private sale	$1,230,000 $123.0 p/Share	10,000 Reduced 0.61%	1,624,231 Common Stock
Jun 13 2022	BUY Exercise of conversion of derivative security	$109,000 $10.9 p/Share	10,000 Added 0.61%	1,634,231 Common Stock
May 31 2022	SELL Open market or private sale	$1,223,867 $145.18 p/Share	8,430 Reduced 0.52%	1,624,231 Common Stock
May 31 2022	BUY Exercise of conversion of derivative security	$7,357 $0.99 p/Share	7,431 Added 0.45%	1,632,661 Common Stock
May 27 2022	BUY Exercise of conversion of derivative security	$327,278 $135.8 p/Share	2,410 Added 0.15%	1,625,230 Common Stock
May 24 2022	SELL Open market or private sale	$683,000 $136.6 p/Share	5,000 Reduced 0.31%	1,622,820 Common Stock
May 24 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,627,820 Common Stock
May 23 2022	SELL Open market or private sale	$686,500 $137.3 p/Share	5,000 Reduced 0.31%	1,622,820 Common Stock
May 23 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,627,820 Common Stock
May 13 2022	SELL Open market or private sale	$1,990,350 $132.69 p/Share	15,000 Reduced 0.92%	1,622,820 Common Stock
May 13 2022	BUY Exercise of conversion of derivative security	$89,250 $5.95 p/Share	15,000 Added 0.91%	1,637,820 Common Stock
May 12 2022	SELL Open market or private sale	$605,500 $121.1 p/Share	5,000 Reduced 0.31%	1,622,820 Common Stock
May 12 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,627,820 Common Stock
May 10 2022	SELL Open market or private sale	$31,288 $133.71 p/Share	234 Reduced 0.01%	1,622,820 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account